The moderating effect of anxiety sensitivity on caffeine-induced hypoalgesia in healthy women

被引:6
|
作者
Keogh, E [1 ]
Chaloner, N [1 ]
机构
[1] Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England
关键词
pain; caffeine; anxiety sensitivity; threshold; women;
D O I
10.1007/s00213-002-1280-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Caffeine is an analgesic adjuvant, but also has panicogenic properties. Anxiety sensitivity is a trait vulnerability factor related to negative responses to pain, and is known to moderate negative psychological responses to caffeine. Objectives: The current study sought to investigate whether anxiety sensitivity moderates the effect caffeine has on the pain responses of healthy women. Methods: Caffeine (250 mg) was administered to women pre-selected as high, medium or low in anxiety sensitivity. Measures of arousal and mood were taken before and after drug administration. The cold pressor pain task was used to induce pain. Pain threshold, tolerance, sensory and affective pain responses were also recorded. Results: Caffeine increased systolic blood pressure and mood. Additionally, those low in anxiety sensitivity exhibited caffeine-induced improvement in negative mood (less depressed) and caffeine-related hypoalgesia. Conclusions: These results suggest that the analgesic effects of caffeine may depend on anxiety sensitivity status, and that the fear of bodily sensations should be considered in pain management programmes.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 30 条
  • [1] EFFECT OF PROSTAGLANDIN INHIBITION ON CAFFEINE-INDUCED HYPERCALCIURIA IN HEALTHY WOMEN
    WHITING, SJ
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1990, 1 (04) : 201 - 205
  • [2] A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers
    Paterson, Louise M.
    Wilson, Sue J.
    Nutt, David J.
    Hutson, Peter H.
    Ivarsson, Magnus
    PSYCHOPHARMACOLOGY, 2007, 191 (04) : 943 - 950
  • [3] Obesity as an influencing factor for the occurrence of caffeine-induced effects in women
    Domaszewski, Przemyslaw
    Konieczny, Mariusz
    Pakosz, Pawel
    Matuska, Jakub
    Skorupska, Elzbieta
    Santafe, Manel M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (04)
  • [4] A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers
    Louise M. Paterson
    Sue J. Wilson
    David J. Nutt
    Peter H. Hutson
    Magnus Ivarsson
    Psychopharmacology, 2007, 191 : 943 - 950
  • [5] Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
    Alsene, K
    Deckert, J
    Sand, P
    de Wit, H
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) : 1694 - 1702
  • [6] Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety
    Karen Alsene
    Jürgen Deckert
    Philipp Sand
    Harriet de Wit
    Neuropsychopharmacology, 2003, 28 : 1694 - 1702
  • [7] Expression of aphidicolin, FUdR and caffeine-induced fragile sites in lymphocytes of healthy Turkish individuals
    Güven, GS
    Hacihanefioglu, S
    Cenani, A
    GENETICA, 1999, 105 (01) : 109 - 116
  • [8] Manilkara zapota Leaves and Anxiolytic Activity: Potential Benefits in Caffeine-Induced Experimental Animals with Anxiety
    Bhavani, Keserla
    Monisha, S.
    Muthukumar, A.
    Srivastava, Noopur
    Paarakh, Padmaa M.
    Alobid, Saad
    Das, Kuntal
    Almoteer, Ali Ibrahim
    Almadani, Moneer E.
    Ahmad, Fuzail
    Gilkaramenthi, Rafiulla
    Jibreel, Ebtesam Abdulrahman
    Rabbani, Syed Imam
    Asdaq, Syed Mohammed Basheeruddin
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2024, 38 (02) : 1503 - 1514
  • [9] Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety
    Childs, Emma
    Hohoff, Christa
    Deckert, Juergen
    Xu, Ke
    Badner, Judith
    de Wit, Harriet
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (12) : 2791 - 2800
  • [10] Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
    Emma Childs
    Christa Hohoff
    Jürgen Deckert
    Ke Xu
    Judith Badner
    Harriet de Wit
    Neuropsychopharmacology, 2008, 33 : 2791 - 2800